Pailin Biological Co., Ltd.
SZSE · 000403
Market Cap$12.2B
Revenue$2.6B
P/E Ratio34.5
Employees2755
Listed OnSZSE
Ticker000403
IndustryBiotechnology
CEO / ExecMr. Xiankui Rong
HeadquartersTaiyuan
MarketMainland China
Websitewww.slbiop.com
Overview
Pacific Shuanglin Bio-pharmacy Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of blood products in China and internationally. The company offers human serum albumin, human immunoglobulin (PH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin, rabies immunoglobulin, human coagulation factor VIII, human fibrinogen, lyophilized intravenous immunoglobulin (pH4), hepatitis B immunoglobulin (pH4), and human prothromb
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.